These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12947084)

  • 21. A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling.
    Yang RB; Ng CK; Wasserman SM; Kömüves LG; Gerritsen ME; Topper JN
    J Biol Chem; 2003 Aug; 278(35):33232-8. PubMed ID: 12807873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
    Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
    Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific in vivo knockdown of protein function by intrabodies.
    Marschall AL; Dübel S; Böldicke T
    MAbs; 2015; 7(6):1010-35. PubMed ID: 26252565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 2002 Sep; 267(2):213-26. PubMed ID: 12165442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
    Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF
    Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and regulation of the receptor tyrosine kinase Tie-1 in platelets.
    Tsiamis AC; Hayes P; Box H; Goodall AH; Bell PR; Brindle NP
    J Vasc Res; 2000; 37(6):437-42. PubMed ID: 11146396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulum.
    Böldicke T; Somplatzki S; Sergeev G; Mueller PP
    Methods; 2012 Mar; 56(3):338-50. PubMed ID: 22037249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
    Sato TN; Tozawa Y; Deutsch U; Wolburg-Buchholz K; Fujiwara Y; Gendron-Maguire M; Gridley T; Wolburg H; Risau W; Qin Y
    Nature; 1995 Jul; 376(6535):70-4. PubMed ID: 7596437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3.
    Rauchenberger R; Borges E; Thomassen-Wolf E; Rom E; Adar R; Yaniv Y; Malka M; Chumakov I; Kotzer S; Resnitzky D; Knappik A; Reiffert S; Prassler J; Jury K; Waldherr D; Bauer S; Kretzschmar T; Yayon A; Rothe C
    J Biol Chem; 2003 Oct; 278(40):38194-205. PubMed ID: 12842902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization.
    Nowak G; Karrar A; Holmén C; Nava S; Uzunel M; Hultenby K; Sumitran-Holgersson S
    Circulation; 2004 Dec; 110(24):3699-707. PubMed ID: 15381639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
    Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
    J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
    Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.
    Kriehuber E; Breiteneder-Geleff S; Groeger M; Soleiman A; Schoppmann SF; Stingl G; Kerjaschki D; Maurer D
    J Exp Med; 2001 Sep; 194(6):797-808. PubMed ID: 11560995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor cells for tissue transplantation.
    Beyer F; Doebis C; Busch A; Ritter T; Mhashilkar A; Marasco WM; Laube H; Volk HD; Seifert M
    J Gene Med; 2004 Jun; 6(6):616-23. PubMed ID: 15170732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
    Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells.
    Li XF; Charnock-Jones DS; Zhang E; Hiby S; Malik S; Day K; Licence D; Bowen JM; Gardner L; King A; Loke YW; Smith SK
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1823-34. PubMed ID: 11297624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.